Perifosine enhances the sensitivity to oxaliplatin and 5-fluorourasil in PIK3CA-mutated colon cancer

被引：0
|
作者：
Takefuji, Honoka [1 ]
Tsubaki, Masanobu [1 ]
Takeda, Tomoya [1 ]
Matsuda, Takuya [1 ]
Kimura, Akihiro [1 ]
Nishida, Shozo [1 ]
机构：
[1] Kindai Univ, Dept Pharmacotherapy, Fac Pharm, Higashiosaka, Osaka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1343
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [41] Alpelisib for PIK3CA-mutated advanced gynecological cancers: first clues of clinical activity
    Passarelli, Anna
    Carbone, Maria Vittoria
    Pignata, Sandro
    Mazzeo, Roberta
    Lorusso, Domenica
    Scambia, Giovanni
    Canova, Stefania
    Di Palma, Teresa
    Tasca, Giulia
    Mantiero, Mara
    Naglieri, Emanuele
    Andreetta, Claudia
    Rauso, Martina
    Brunetti, Anna Elisabetta
    Laera, Letizia
    Abeni, Chiara
    Scandurra, Giuseppa
    Gambaro, Anna Rita
    Pastore, Alessia
    Bengala, Carmelo
    Gunnellini, Marco
    Farolfi, Alberto
    Spinello, Maurizio
    Bartoletti, Michele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A277 - A278
  • [42] Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity
    Passarelli, Anna
    Carbone, Vittoria
    Pignata, Sandro
    Mazzeo, Roberta
    Lorusso, Domenica
    Scambia, Giovanni
    Canova, Stefania
    Di Palma, Teresa
    Tasca, Giulia
    Mantiero, Mara
    Naglieri, Emanuele
    Andreetta, Claudia
    Rauso, Martina
    Brunetti, Anna Elisabetta
    Laera, Letizia
    Abeni, Chiara
    Scandurra, Giuseppa
    Gambaro, Anna Rita
    Pastore, Alessia
    Bengala, Carmelo
    Gunnellini, Marco
    Farolfi, Alberto
    Spinello, Maurizio
    Bartoletti, Michele
    GYNECOLOGIC ONCOLOGY, 2024, 183 : 61 - 67
  • [43] Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
    Yeom, Jiah
    Cho, Yoonju
    Ahn, Seoungyob
    Jeung, Soyoung
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [44] Deactivation of glutaminolysis sensitizes PIK3CA-mutated colorectal cancer cells to aspirin-induced growth inhibition
    Boku, Shogen
    Watanabe, Motoki
    Iizuka, Mahiro
    Sowa, Yoshihiro
    Masuda, Mitsuharu
    Iizumi, Yosuke
    Narita, Takumi
    Satake, Hironaga
    Sakai, Toshiyuki
    Mutoh, Michihiro
    CANCER SCIENCE, 2022, 113 : 1141 - 1141
  • [45] Network Analysis Reveals A Signaling Regulatory Loop in PIK3CA-mutated Breast Cancer Predicting Survival Outcome
    McGee, Shauna R.
    Tibiche, Chabane
    Trifiro, Mark
    Wang, Edwin
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2017, 15 (02) : 121 - 129
  • [46] Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition
    Boku, Shogen
    Watanabe, Motoki
    Sukeno, Mamiko
    Yaoi, Takeshi
    Hirota, Kiichi
    Iizuka-Ohashi, Mahiro
    Itoh, Kyoko
    Sakai, Toshiyuki
    CANCERS, 2020, 12 (05)
  • [47] Next-Generation Sequencing-Based Analysis of Clinical and Pathological Features of PIK3CA-Mutated Breast Cancer
    Smok-Kalwat, Jolanta
    Chmielewski, Grzegorz
    Stando, Rafal
    Sadowski, Jacek
    Macek, Pawel
    Kowalik, Artur
    Nowak-Ozimek, Ewelina
    Gozdz, Stanislaw
    DIAGNOSTICS, 2023, 13 (18)
  • [48] Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer
    Kodahl, Annette R.
    Ehmsen, Sidse
    Pallisgaard, Niels
    Jylling, Anne M. B.
    Jensen, Jeanette D.
    Laenkholm, Anne-Vibeke
    Knoop, Ann S.
    Ditzel, Henrik J.
    MOLECULAR ONCOLOGY, 2018, 12 (06): : 925 - 935
  • [49] In vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines
    Maeda, Marika
    Ochiai, Kazuhiko
    Michishita, Masaki
    Morimatsu, Masami
    Sakai, Hiroki
    Kinoshita, Nayuta
    Sakaue, Motoharu
    Onozawa, Eri
    Azakami, Daigo
    Yamamoto, Masami
    Ishioka, Katsumi
    Sadahira, Takuya
    Watanabe, Masami
    Tanaka, Yoshikazu
    ONCOLOGY REPORTS, 2022, 47 (04)
  • [50] Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer
    Jeong, Yeong Gyu
    Katuwal, Nar Bahadur
    Kang, Min Sil
    Ghosh, Mithun
    Hong, Sa Deok
    Park, Seong Min
    Kim, Seul-Gi
    Kim, Tae Hoen
    Moon, Yong Wha
    CANCERS, 2023, 15 (19)
12345